Viewing Study NCT00325351


Ignite Creation Date: 2025-12-24 @ 11:42 PM
Ignite Modification Date: 2026-02-23 @ 1:21 AM
Study NCT ID: NCT00325351
Status: COMPLETED
Last Update Posted: 2021-04-08
First Post: 2006-05-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: ZK-Epo Given With Carboplatin in Patients With Recurrent Ovarian Cancer
Sponsor: Bayer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module